Indian drugmakers notch cleaner USFDA inspections as global outcomes worsen

Published on: Feb. 22, 2026, 11:18 a.m. | Source: Business Standard

USFDA data show OAI rates for Indian pharma plants falling to 8% by 2025 even as global outcomes worsen, reflecting stronger quality systems, technology adoption and compliance culture

Checkout more news

✅ Secure, cloud-based clinic management software

Manage digital prescriptions, appointments, patient records, billing, files, and reports — everything your clinic needs in one powerful platform.

Know more